Genetic predisposition to breast cancer: Past, present, and future

被引:196
|
作者
Turnbull, Clare [1 ]
Rahman, Nazneen [1 ]
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
基金
英国医学研究理事会;
关键词
BRCA*; allele; familial; susceptibility; penetrance;
D O I
10.1146/annurev.genom.9.081307.164339
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years, our understanding of genetic predisposition to breast cancer has advanced significantly. Three classes of predisposition factors, categorized by their associated risks of breast cancer, are currently known. BRCA1 and BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional cloning. Mutational screening of genes functionally related to BRCA1 and/or BRCA2 has revealed four genes, CHEK2, ATM, BRIP1, and PALB2; mutations in these genes are rare and confer an intermediate risk of breast cancer. Association studies have further identified eight common variants associated with low-penetrance breast cancer predisposition. Despite these discoveries, most of the familial risk of breast cancer remains unexplained. In this review, we describe the known genetic predisposition factors, expound on the methods by which they were identified, and consider how further technological and intellectual advances may assist in identifying the remaining genetic factors underlying breast cancer susceptibility.
引用
收藏
页码:321 / 345
页数:25
相关论文
共 50 条
  • [31] Neoadjuvant endocrine therapy for breast cancer:: past, present and future
    Barnadas, Agusti
    Gill, Miguel
    Sanchez-Rovira, Pedro
    Llombart, Antonio
    Adrover, Encarna
    Estevez, Laura G.
    de la Haba, Juan
    Calvo, Lourdes
    ANTI-CANCER DRUGS, 2008, 19 (04) : 339 - 347
  • [32] Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches
    Schick, Jason
    Ritchie, Raquel P.
    Restini, Carolina
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2021, 15
  • [33] Aromatase inhibitors: past, present and future in breast cancer therapy
    Udayan Dutta
    Kartikeya Pant
    Medical Oncology, 2008, 25 : 113 - 124
  • [34] Prognostic and predictive biomarkers in breast cancer: Past, present and future
    Nicolini, Andrea
    Ferrari, Paola
    Duffy, Michael J.
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 56 - 73
  • [35] Oestrogen and progesterone receptors in breast cancer: past, present and future
    Barnes, DM
    Hanby, AM
    HISTOPATHOLOGY, 2001, 38 (03) : 271 - 274
  • [36] Understanding breast cancer screening-past, present, and future
    Sitt, Jacqueline C. M.
    Lui, C. Y.
    Sinn, Lorraine H. Y.
    Fong, Julian C. Y.
    HONG KONG MEDICAL JOURNAL, 2018, 24 (02) : 166 - 174
  • [37] Multigene prognostic tests in breast cancer: past, present, future
    Balázs Győrffy
    Christos Hatzis
    Tara Sanft
    Erin Hofstatter
    Bilge Aktas
    Lajos Pusztai
    Breast Cancer Research, 17
  • [38] GENETIC MONITORING - PAST, PRESENT AND FUTURE
    DABNEY, BJ
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1984, 26 (04) : 298 - 298
  • [39] Genetic therapy - Past, present, and future
    Flotte, TR
    Ferkol, TW
    PEDIATRIC CLINICS OF NORTH AMERICA, 1997, 44 (01) : 153 - +
  • [40] GENETIC COUNSELING - PAST, PRESENT AND FUTURE
    ROSSMANN, DL
    SCHULL, WJ
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1973, 63 (11) : 925 - 926